Amyl Therapeutics
Amyl Therapeutics unique technology offers a curative solution for all forms of amyloid mediated diseases
3
Funding Rounds
$33.6m
Money raised
Overview
Amyl Therapeutics unique technology offers a curative solution for all forms of amyloid mediated diseases
- Website:
- Business model: B2B
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Fl***** Gr** |
|
- | - |
Funding
Funding series
Funding Series Analysis
The company Amyl Therapeutics has raised a total of $33.6m in funding over 3 rounds.
Key Insights:
- Amyl Therapeutics November 2023 Series A Funding Round: $5.7m
- Amyl Therapeutics November 2023 Series A Funding Round: $5.7m
- Amyl Therapeutics Series A round, June 2021: $22.2m
Amyl Therapeutics November 2023 Series A Funding Round
$5.7m
Amyl Therapeutics November 2023 Series A Funding Round
$5.7m
Amyl Therapeutics Series A round, June 2021
$22.2m
Industries
Amyl Therapeutics is active in the following industries: